Table 2.
Statistical analysis of demographic and clinical baseline characteristics for optimal and non-optimal PaCO2 groups.
Parameter | Optimal PaCO2 | Non optimal PaCO2 | p | OR | 95% CI |
---|---|---|---|---|---|
%/mean ± SD | %/mean ± SD | ||||
Age (years) | 52.7 ± 14.0 | 54.9 ± 13.6 | 0.136 | – | – |
Sex female | 67.9% | 66.4% | 0.766 | 1.07 | 0.69–1.66 |
WFNS 4/5 | 31.2% | 50.8% | < 0.001 | 0.44 | 0.28–0.68 |
Fisher 3/4 | 90.4% | 91.3% | 0.777 | 0.90 | 0.42–1.91 |
Treatment clipping | 37.6% | 42.0% | 0.399 | 0.83 | 0.55–1.27 |
Statistically significant p-values are marked bold.